Oncology and Hematology

Oncology/Hematology Clinical Research Studies

The Division of Oncology and Hematology has a long tradition of pioneering research in the field of cancer and its treatment. There are numerous ongoing state-of-the art clinical trials that are available to patients with various cancers. The Division has been a main member of the Cancer and Leukemia Group B (CALGB) since 1996. The CALGB is one of three multidisciplinary cooperative cancer treatment groups funded by the National Cancer Institute. Each cooperative group focuses on particular areas of cancer research, often collaborating in large-scale clinical trials. The Division is also an active Research center of the Center for International Blood and Marrow Transplant Research (formerly IBMTR/ABMTR) and is a core center involved in the Blood and Marrow Transplant Clinical Trial Network (BMT-CTN). The BMT-CTN is funded by the National Cancer Institute and is a network of transplant centers in the US actively recruiting patients to various clinical protocols in stem cell transplantation. The Oncology and Hematology Division is also known for the establishment of the Nebraska Lymphoma Study Group (NLSG) and is involved in various industry-sponsored clinical research studies.

Additionally, all faculty members of the Division participate in the various programs/studies conducted within the UNMC Eppley Cancer Center.